Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2015 by Emory University
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
Temple University
University of Michigan
Ohio University
Information provided by (Responsible Party):
Guillermo Umpierrez, Emory University
ClinicalTrials.gov Identifier:
NCT01845831
First received: April 30, 2013
Last updated: March 6, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)